BiotechTube
Home/uniQure/Matt Kapusta
MK

Matt Kapusta

Chief Executive Officer

uniQure

Therapeutic Areas

Neurodegenerative DiseasesGenetic Disorders

uniQure Pipeline

DrugIndicationPhase
AMT-130Huntington's DiseasePhase I/II
AMT-162SOD1-ALSPreclinical
AMT-260Temporal Lobe EpilepsyPreclinical
Undisclosed Gene TherapyFabry DiseasePreclinical
Undisclosed ProgramAlzheimer's DiseaseResearch

Leadership Team at uniQure

WA
Walid Abi-Saab, M.D.
Chief Medical Officer
AA
Amin Abujoub, Ph.D.
Chief Technical Operations Officer
EB
Erin Boyer
Chief People and Culture Officer
CK
Christian Klemt
Chief Financial Officer
KO
Kylie O’Keefe
Chief Customer and Strategy Officer
RP
Richard Porter, Ph.D.
Chief Business and Scientific Officer
JP
Jeannette Potts, Ph.D., J.D.
Chief Legal and Compliance Officer
DM
David Meek
Non-Executive Chairman of the Board
View full uniQure profile